OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 14

Showing 14 citing articles:

Molecular characterization of SARS-CoV-2 nucleocapsid protein
Yanping Huang, Junkai Chen, Siwei Chen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6

Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 18

The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
Wanchen Song, Zhongbiao Fang, Feike Ma, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
Xu Song, Jiali Qian, Chuanhong Wang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 10

Unraveling the role of the nucleocapsid protein in SARS-CoV-2 pathogenesis: From viral life cycle to vaccine development
Yousra A. El‐Maradny, Moustafa A. Badawy, Kareem I. Mohamed, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135201-135201
Closed Access | Times Cited: 2

Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants
Rodrigo Nunes Rodrigues‐da‐Silva, Fernando Conte, Gustavo da Silva, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 923-923
Open Access | Times Cited: 5

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source
Josip Rudar, Peter Kruczkiewicz, Oksana Vernygora, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1

The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity
M.A. Marquez-Monino, Clara M. Santiveri, Patricia de León, et al.
Structure (2024)
Closed Access

Recent developments in the therapeutics of SARS-CoV-2 infection
Priyanka Nagu, Arun Parashar, Pankaj Sharma, et al.
One Health Bulletin (2024) Vol. 4, Iss. 4, pp. 143-156
Open Access

SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis
Xiao Guo, Shimin Yang, Zeng Cai, et al.
The Journal of Cell Biology (2024) Vol. 224, Iss. 1
Closed Access

Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain
Ahmad Ghorbani, Faezeh Maghsood, Hamidreza Yadegari, et al.
Journal of Medical Microbiology (2023) Vol. 72, Iss. 6
Closed Access

Page 1

Scroll to top